rigel.com - RIGL Net Assets per Single Share

Graphic logo of Rigel Pharmaceuticals (RIGL)

This chart shows that the current share price of Rigel Pharmaceuticals (RIGL), whose business is based on the development of immune drugs, is 23.03. Management demonstrates professionalism in niche marketing and transparency in the distribution of core medications. The environmental development vector focuses on minimizing water consumption and treating laboratory waste. Meanwhile, Rigel Pharmaceuticals (RIGL) maintains high pricing power for its original therapies despite pressure from insurance companies.

Rigel Pharma (RIGL): Share Book Value from 07/04/2022 to 10/27/2026

rigel.com - analytical breakdowns and key metrics (RIGL)

- price and consensus price forecast:
Stock Price Rigel Pharmaceuticals Inc|RIGL - Analyst Target Range
- market capitalization data:
Market Value Rigel Pharmaceuticals, Inc.|RIGL - Total Company Value
- book capitalization data:
Net Assets per Single Share Rigel Pharmaceuticals|RIGL - Net Asset Value|Market Capitalization to Book Value Ratio rigel.com|RIGL - Aggregate Asset Value
- debt and liquidity data:
Total Debt to Capital Rigel Pharmaceuticals|RIGL - Long-Term Debt to Capital|Short-Term Debt to Equity Rigel Pharmaceuticals, Inc.|RIGL - Aggregate Debt Obligations|Debt to Book Capitalization Ratio Rigel Pharmaceuticals, Inc.
Fundamental company valuation:Rigel Pharmaceuticals Inc - RIGL
Manufactured products of Rigel Pharmaceuticals, Inc.

It is critical for investors to determine the extent to which the market price of Rigel Pharmaceuticals (RIGL) is justified by tangible assets. This indicator calculates the residual value of net assets per share after all liabilities have been settled. By analyzing the book value per share, one can assess the actual asset backing of the business. Growth in this metric confirms the accumulation of resources; for Rigel Pharmaceuticals (RIGL), this reflects the capitalization of kinase inhibitor patents and the commercial success of Tavalisse.

Competitors of Rigel Pharmaceuticals (RIGL)

Book Value per Share ARGX|BNTX: Book Value of One Share|Abivax Corp (ABVX) - Net Assets per Single Share|ADMA (admabiologics.com) - Net Assets per Single Share|Net Assets per Single Share Protagonist PTGX|Share Book Value Immunovant Inc|Kiniksa Pharmaceuticals Ltd (KNSA) - Book Value per Share|Accounting Value of a Share Grifols Biemat (GRFS)|Book Value per Share ADPT (Adaptive Biotechnologies)|celldex.com - Book Value per Share|Net Assets per Single Share Aurinia Pharmaceuticals Inc. (AUPH)|BCRX: Accounting Value of a Share|VERA (Vera Pharma) - Net Assets per Single Share|Dianthus Corp (DNTH) - Accounting Value per Share|PHVS (Pharvaris N.V.) - Book Value per Share|Book Value per Share AbCellera Corp (ABCL)|Tourmaline Bio (TRML) - Accounting Value per Share|Accounting Value of a Share Precigen Inc (PGEN)|Book Value per Share PHAR|Nektar Corp - Net Assets per Share|UPB: Net Assets per Single Share|ZBIO: Accounting Value per Share|IMNM (Immunome) - Net Assets per Single Share|Accounting Value per Share Gossamer Bio Inc|KALV (KalVista Pharmaceuticals Inc) - Accounting Value per Share|Book Value per Share SEPN|Net Assets per Single Share Pieris Pharmaceuticals PVLA|Equity per Share savarapharma.com (SVRA)|ANAB: Book Value per Share|Astria Therapeutics Inc - Net Asset Value per Share|Net Assets per Single Share enGene Bio (ENGN)|RAPT - Accounting Value of a Share|aerovatetx.com - Book Value per Share|aclaristx.com (ACRS) - Net Assets per Share|Kyverna Therapeutics, Inc. - Book Value per Share|Book Value of One Share Tiziana Life Sciences Ltd.|Cabaletta Bio, Inc - Book Value per Share|Net Asset Value per Share VTYX (Ventyx Biosciences, Inc)|Net Assets per Single Share Theratechnologies Inc. THTX|AVTX - Net Assets per Single Share|Accounting Value per Share Eledon Pharmaceuticals, Inc. (ELDN)|AGEN: Accounting Value of a Share|Net Assets per Single Share Climb Bio, Inc. (CLYM)|Zura Bio Ltd (ZURA) - Share Book Value|ATYR - Book Value per Share|Accounting Value of a Share Adagene Corp|Book Value per Share IMA|Book Value per Share STTK (shattucklabs.com)|Net Assets per Single Share Equillium|Connect Biopharma Holdings - Accounting Value of a Share|IMUX: Net Assets per Single Share|ATRA - Accounting Value per Share|IFRX: Book Value per Share|X4 Pharmaceuticals Inc. (XFOR) - Book Value per Share|Book Value per Share ACET|Accounting Value per Share Celularity Corp|INmune Bio, Inc. - Book Value per Share|Net Asset Value per Share barinthusbio.com BRNS|Accounting Value per Share KZR (Kezar Life Sciences, Inc.)|SABS - Book Value per Share|Accounting Value per Share Akari Therapeutics plc AKTX|ENLV - Book Price of a Share|q32bio.com - Book Value per Share|geovax.com (GOVX) - Net Assets per Share|Book Value per Share EDSA|Accounting Value per Share iBio Inc|Book Value per Share CARM|Book Value per Share XTLB (XTL Bio)|Net Assets per Single Share Bolt Biotherapeutics, Inc. BOLT|HCW Biologics, Inc. - Net Assets per Single Share|Net Assets per Single Share APVO (Aptevo)|AIM: Net Assets per Share|Net Assets per Single Share aditxt.com ADTX|GRI Bio Corporation (GRI) - Accounting Value of a Share|XRTX: Book Value per Share|Net Assets per Share reshapelifesciences.com|REVB: Book Value per Share|Book Value of One Share INDP (Indaptus Therapeutics Inc)|Net Assets per Single Share Scinai SCNI|CalciMedica Inc - Net Assets per Single Share|Net Assets per Single Share Affimed Therapeutics|ALLK - Share Book Value|Book Value per Share hookipapharma.com HOOK|IGM Biosciences (IGMS) - Accounting Value of a Share|ITOS (iTeos) - Book Value per Share|Book Value per Share OCEA|TC Biopharm (TCBP) - Net Assets per Single Share|Accounting Value of a Share THRD (thirdharmonicbio.com)